SAVE - The sleep apnea cardiovascular endpoints study results

28 August 2016 (17:16 - 17:26)

Organised by:

Video

Sign in for access options

ESC TV

Slides

About the speaker

Professor Doug McEvoy

Flinders Medical Centre, Bedford Park (Australia)

11 More presentations in this session

Presentation thumbnail

Optimal dual antiplatelet treatment (DAPT) duration following drug eluting stent with bioabsorbable polymer and abluminal coating, NIPPON study

Professor M. Nakamura (Tokyo, JP)

Presentation thumbnail

Optimal DAPT after DES - Discussant review.

Professor P. Steg (Paris, FR)

Presentation thumbnail

Optimal DAPT after DES - Panel discussion.

Presentation thumbnail

ANTARCTIC - Platelet function monitoring in elderly patients stented for an acute coronary syndrome

Professor G. Montalescot (Paris, FR)

Presentation thumbnail

ANTARCTIC - Discussant review.

Professor S. Kristensen (Aarhus, DK)

Access the full session

Session thumbnail

Hot Line preventive strategies 1

The Event

ESC Congress 2016

28 August 2016 17:16 CET

You may be interested in

Congress Presentation

Sleep apnoea is associated with long-term cardiovascular outcomes in patients undergoing coronary artery bypass grafting

26 August 2023

Congress Presentation

Does sleep apnea home-evaluation and potential treatment improve quality of life in patients with atrial fibrillation? Rationale and design of the VIR-SAAF study

12 April 2026

ESC TV Today

Episode 5: Aortic aneurysms - Return to elite sports after a severe cardiac event

21 November 2024

Congress Presentation

Pharmacological inhibition of SK-channels with AP14145 prevents atrial arrhythmogenic changes in a porcine model for obstructive respiratory events.

4 April 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources